[Ambroxol in the treatment of idiopathic respiratory distress syndrome].
The authors treated five premature infants with idiopathic respiratory distress syndrome with ambroxol, using its action on type II pneumocytes and thus also on surfactant formation. In all infants improvement of the clinical condition was achieved, no side-effects were observed.
Durisová
A
A
Novorodenecké oddelenie nemocnice, Nitra.
D000551:Ambroxol / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*
D000551:Ambroxol